IV 
111TH CONGRESS 
2D SESSION 
H. RES. 1433 
Expressing support for designation of September 2010 as Blood Cancer 
Awareness Month. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 10, 2010 
Mr. JONES (for himself, Ms. MARKEY of Colorado, Mr. WHITFIELD, and Mr. 
LOEBSACK) submitted the following resolution; which was referred to the 
Committee on Energy and Commerce 
RESOLUTION 
Expressing support for designation of September 2010 as 
Blood Cancer Awareness Month. 
Whereas blood-related cancers currently afflict more than 
900,000 people in the United States, with an estimated 
150,000 new cases diagnosed each year; 
Whereas leukemia, lymphoma, multiple myeloma, myelodys-
plastic syndromes, and myeloproliferative disorders will 
kill more than 50,000 people in the United States this 
year; 
Whereas Congress, in the National Cancer Act, established 
an aggressive Federal program for the diagnosis, preven-
tion, and treatment of cancer; 
Whereas Congress has maintained a steady investment in 
cancer research to answer basic questions about the 
VerDate Mar 15 2010 
23:49 Jun 10, 2010
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1433.IH
HR1433
jbell on DSKDVH8Z91PROD with BILLS
•HRES 1433 IH 
causes of cancer and to develop new treatments for can-
cer; 
Whereas the Federal investment in cancer research and con-
trol has contributed to important progress in under-
standing and treating some blood cancers and yielded sig-
nificant advances in survival for some forms of blood can-
cer; 
Whereas continued investment and innovation is critical to 
the early diagnosis and the more effective and safer 
treatment for blood cancers where research and treat-
ment advances have to date been limited; 
Whereas strategies to enhance and strengthen the cancer 
clinical research program and boost participation in clin-
ical trials are necessary to achieve blood cancer treatment 
advances; 
Whereas survivors of blood cancer may experience serious late 
and long-term effects of their treatment and may need 
life-long follow-up and survivorship care; 
Whereas Congress has provided strong support to blood can-
cer research and has focused special attention on increas-
ing awareness of blood cancers and intensifying the blood 
cancer research program; 
Whereas the House of Representatives will continue to pro-
vide support for research for a cure for leukemia, 
lymphoma, multiple myeloma, myelodysplastic syndromes, 
and myeloproliferative disorders; and 
Whereas September 2010 would be an appropriate month to 
designate as Blood Cancer Awareness Month: Now, 
therefore, be it 
Resolved, That the House of Representatives— 
VerDate Mar 15 2010 
23:49 Jun 10, 2010
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HR1433.IH
HR1433
jbell on DSKDVH8Z91PROD with BILLS
•HRES 1433 IH 
(1) supports the designation of Blood Cancer 
Awareness Month to enhance the understanding of 
blood-related cancers, increase support for funding 
research to find a cure for blood cancers, encourage 
studies of the cause and prevention of blood cancers 
to reduce the number of new cases, and enhance un-
derstanding of clinical trials to boost provider and 
patient participation and accelerate the pace of clin-
ical research; 
(2) encourages participation in voluntary activi-
ties to support blood cancer research and education; 
and 
(3) respectfully requests the Clerk of the House 
to transmit a copy of this resolution to the American 
Society of Hematology, the International Myeloma 
Foundation, the Lymphoma Research Foundation, 
the Multiple Myeloma Research Foundation, and 
The Leukemia & Lymphoma Society voluntary 
health organizations dedicated to finding a cure for 
blood cancers. 
Æ 
VerDate Mar 15 2010 
23:49 Jun 10, 2010
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR1433.IH
HR1433
jbell on DSKDVH8Z91PROD with BILLS